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INTRODUCTION:  We  report  a case  with lymph  node  metastasis  of  osteosarcoma,  which  is  a rare  entity  in
comparison  to hematogeneous  lung  or bone  metastasis.
PRESENTATION  OF  CASE:  Twenty-seven  years  old  male  patient  referred  to our  clinic  complaining  of  ongo-
ing left knee  pain  and  swelling  since  one  month  without  a history  of  prior  trauma.  Magnetic  resonance
imaging  (MRI)  revealed  a mass  of  malignant  nature  which  causes  more  prominent  expansion  and  destruc-
tion  of the  bone  distally  with  periosteal  reaction.  A  lymphadenomegaly  16 mm  × 13 mm  in diameter  was
also  present  in the  popliteal  fossa  having  the  same  signal  pattern  with  the  primary  lesion.  Thirteen
weeks  following  the  ﬁrst  referral  of the patient,  wide  resection  and  reconstruction  with  modular  tumor
prosthesis  was  performed.  Popliteal  lymph  node  was  excised  through  the  same  incision.  Pathologic  exam-
ination  of the  resected  speciman  reported  osteoblastic  osteosarcoma.  The  lymph  node  extirpated  from
the  popliteal  fossa  was reported  to  be  a metastasis  of the primary  tumor.
DISCUSSION:  Osteosarcoma  of  the long  bones  is the most  common  primary  malignant  bone  neoplasm
of  both  childhood  and  adulthood.  Osteosarcomas  commonly  metastasize  hematogeneously  to  the lungs
and bones.  Lymph  node  metastasis  is  a rare entity.  Similar  studies  report  rates  between  2.3% and  4%.  It
is  not  clearly  explained,  how  lymph  node  metastasis  in osteosarcoma  occurs  despite  lack  of lymphatic
drainage  in  normal  cortical  and  spongious  bone.
CONCLUSION:  Lymph  node  metastasis  of osteosarcoma  is  a rare entity  and  metastatic  patterns  could  not
be clearly  explained.  On  the  other  hand,  the  effects  of lymph  node  metastasis  on  prognosis  are  also  not
clearly  deﬁned  and  further  studies  are  needed.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
We  report a case with lymph node metastasis of osteosarcoma,
hich is a rare entity in comparison to hematogeneous lung or bone
etastasis.
Osteosarcoma of the long bones is the most common pri-
ary malignant bone neoplasm of both childhood and adulthood.
wenty percent of all malignant bone tumors are osteosarcomas.
t is more common in males (1.5:1–2:1) than in females. Distal
emur, proximal tibia and proximal humerus are most commonly
ffected sites where bone growth is fastest.1 Most of osteosarcomas
ccur as conventional osteosarcomas, histologically subdivided as
steoblastic, ﬁbroblastic and chondroblastic types. Osteosarcomas
ommonly metastasize hematogeneously to the lungs and bones.
ymph node metastasis is a rare entity.2–4
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2. Case presentation
Twenty-seven years old male patient referred to our clinic
complaining of ongoing left knee pain and swelling since one
month without a history of prior trauma. Initial radiographic
evaluation showed a sclerotic lesion ﬁlling the whole proximal
tibial epiphysis and metaphysis with extension to diaphysis and
destruction of the anteromedial cortex (Fig. 1a, and b). Mag-
netic resonance imaging revealed a mass of malignant nature
7.6 cm × 7.15 cm × 7.7 cm in diameter and which causes more
prominent expansion and destruction of the bone distally with
periosteal reaction (Fig. 2a and b). Gadollinium-enhanced magnetic
resonance images demonstrated peripheral contrast uptake. A lym-
phadenomegaly 16 mm × 13 mm in diameter was  also present in
the popliteal fossa having the same signal pattern with the pri-
mary lesion. Computerized tomography (CT) scanning of the thorax
showed no lung metastasis.Technetium 99 whole body bone scan depicted only the proxi-
mal  tibial mass and the lymph hode metastasis in a lateral view. The
patient was evaluated by a whole crural MRI, including the knee and
ankle joints, in order not to miss a skip metastasis. Approximately
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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vFig. 1. (a and b) Pre-operative X-ray images demonstrate the lesion.
2 cm long lesion of the cortex, reminding the beads of a rosary,
ithout any cortical expansion in the mid-diaphyseal region was
isplayed. This lesion caused no periosteal reaction and had low
ontrast uptake. CT veriﬁcation of the lesion was performed and it
as associated with the callus formation due to the closed spiral
racture of the tibial shaft which was treated conservatively ﬁve
ears ago (Fig. 3a–c).
Following tru-cut biopsy of the lesion and pathology reports
eing in compliance with osteoblastic osteosarcoma, three cycles of
eoadjuvant chemotherapy was administered. The pain regressed
fter the ﬁrst chemotherapy cycle. The popliteal lymph node had no
nvolution and the main lesion had minimal regression when evalu-
ted by preoperative MRI  (Fig. 4). Thirteen weeks following the ﬁrst
eferral of the patient, wide resection and reconstruction with mod-
lar tumor prosthesis was performed (Fig. 5). Popliteal artery and
ein were explored. Anterior tibial artery and vein were sacriﬁed as
Fig. 2. (a and b) Pre-operative MR images demonstrate the lesion andPEN  ACCESS
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they were within the reactive zone of the tumor. Popliteal lymph
node was excised through the same incision. Soft tissue coverage of
the prosthesis and extansor aparatus reconstruction was achieved
by a medial gastrocnemius rotation ﬂap and split thickness skin
graft (Fig. 6). Pathologic examination of the resected speciman
reported osteoblastic osteosarcoma with a necrosis rate exceeding
90%. The lymph node extirpated from the popliteal fossa was 2 cm in
diameter and was  reported to be a metastasis of the primary tumor.
Following wound healing, 3 cycles of adjuvant chemotherapy was
applied (Fig. 7a and b).
3. Discussion
Twenty to thirty percent of classic osteosarcoma patients have
clinically apparent metastasis when ﬁrst diagnosed.2,5,6 Most com-
mon  metastasis are hematogeneous to the lungs and bones.1–3
Thorax CT for the lung metastasis and bone sintigraphy for the
skeletal metastasis are advised but uncalciﬁed lymph node metas-
tasis might not be detected using Technetium-99 m methylene
diphosphate scintigraphy.2,3,7 Gallium(Ga-67) scintigraphy is a
better choice to detect the uncalciﬁed lymph node metastasis.3
Positron emission tomography (PET) is another choice to evaluate
the metastatic lesions.2 Lymphangiography can be used to identify
an occult metastasis or to avoid local recurrence.8,9
Lymph node metastasis of osteosarcoma is a rare entity (<4%).
Similar studies report rates between 2.3% and 4%.1–4,10–12 It is not
clearly explained, how lymph node metastasis in osteosarcoma
occurs despite lack of lymphatic drainage in normal cortical and
spongious bone.2 The soft tissues like joint capsule or synovium,
being in relation with upper layers of periosteum, have lymphtic
vessels. In a study, J.R. Edwards et al. reported that tumors destruc-
ting cortex and penetrating soft tissue with lymph node metastasis
contained lymphatic vessels. These lymphatics were limited in the
cortex and did not enter medullary canal. In the same study, it
was implied that the macromolecules could reach from medulla
to periosteum through the gaps in the sinusoids of bones by ﬂuid
ﬂow.4 In our case the tumor had destructed the cortex so it was
 the arrows show the lymph node metastasis (sagittal T1–T2).
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hought that the popliteal lymph node metastasis could have been
hrough lymphatics of joint synovium and capsule.
The initial tru-cut and trocar biopsy of the lesion reviewed a
ow grade osteosarcoma but the existence of a pathologic popliteal
ymph node and periosteal reaction of the medial tibial cortex
eminded of a high grade malignancy. A repeated open biopsy
esulted with the diagnosis of a classic osteosarcoma.
Long-term survival rates have increased with patients who
id not have metastasis upon ﬁrst referral and treated with
ppropriate surgery and effective chemotherapy. The 5 year sur-
ival rate of osteosarcoma patients without metastasis is 50–80
ut with the patients who had metastasis when ﬁrst diagnosed,
he 5 year survival rates are around 10–37%.1,2,6,13–18 The mostges demonstrate the lesion.
important (negative) prognostic factor in osteosarcoma is occur-
rence of metastasis when ﬁrst diagnosed. 20–30% of the patients
have lung metastasis when diagnosed.2,14,15 The prognosis of the
patients with solitary and surgically removable lesions are bet-
ter according to patients who have multiple and/or unresectable
lesions of the lungs.2 The most common sites for extrapulmonary
metastasis are vertebras and pelvic bones. Extrapulmonary metas-
tasis is more common below the level of diaphragma for lesions
of femur. In contrast, extrapulmonary metastasis of the humeral
lesions are more common above the diaphragma.9
Another signiﬁcant prognostic factor is tumor necrosis ratio
fallowing neoadjuvant chemothrapy. The pathologist calculates
the ratio of necrotic cells within the resected tumor so that the
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Fig. 4. MR image following neoadjuvant chemotherapy demonstrates the necrosis.
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Fig. 6. Peri-operative photograph shows the reconstruction using the medial head
of  gastrocnemius.Fig. 5. The photograph shows the resectate.
ffectiveness of the neoadjuvant chemotherapeutics can be deter-
ined. The ratio being over 90% like with our case is accepted as a
ositive prognostic factor.19–23
Prognosis is worse with bone metastasis while the effect of
ymph node metastasis on prognosis is not exactly known.2 In a
tudy 74 of 2748 (2.7%) patients with high grade osteosarcoma had
ymph node metastasis when diagnosed and 19 of these were con-
rmed with pathologic studies. These patients were more likely
o have extraskeletal tumors, distant metastases, tumors arising
utside the lower extremity and larger tumors. This study also
oncluded that regional lymph node involvement is a signiﬁcant
rognostic factor independent of metastatic status, extraskeletal
rigin, age and tumor site.12
In conclusion, lymph node metastasis of osteosarcomas is a rare
ntity and metastatic patterns could not be clearly explained. On
he other hand, the effects of lymph node metastasis on prognosis
of the patient) also are not clearly deﬁned and further studies are
eeded.
Fig. 7. (a and b) Reconstruction with tumor prosthesis is seen on the post-operative
X-ray images.
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